T3 Defense (DFNS) wins approval for private placement shares and reverse split authority
Rhea-AI Filing Summary
T3 Defense Inc. reported results of a special stockholder meeting held on June 24, 2026. Stockholders approved issuing additional common shares upon exercise of certain restricted common stock purchase warrants and upon conversion of Series B Convertible Preferred Stock related to the February 2026 private placement, as required by Nasdaq Listing Rules.
They also approved giving the Board authority, for 18 months, to implement a reverse stock split of common stock at a ratio between one-for-two and one-for-250. As of the May 21, 2026 record date, 60,270,525 common shares were outstanding, with 35,716,531 shares present or represented, forming a 59.26% quorum.
Positive
- None.
Negative
- None.
Insights
Shareholders cleared key approvals for prior financing and a potential reverse split.
The special meeting approvals allow T3 Defense to honor terms of its February 2026 private placement by issuing common shares on warrant exercise and Series B preferred conversion, aligning with Nasdaq Listing Rules. This primarily regularizes an already agreed financing structure.
Stockholders also authorized the Board, for 18 months, to execute a reverse stock split within a wide one-for-two to one-for-250 range. The actual impact will depend on whether, when, and at what ratio the Board chooses to act under this authority.
8-K Event Classification
Key Figures
Key Terms
Special Meeting financial
Securities Purchase Agreement financial
Series B Convertible Preferred Stock financial
reverse stock split financial
Nasdaq Listing Rules regulatory
FAQ
What did T3 Defense Inc. (DFNS) stockholders approve at the June 24, 2026 Special Meeting?
What quorum was present for T3 Defense’s June 24, 2026 Special Meeting?
What reverse stock split authority did T3 Defense (DFNS) stockholders grant the Board?
How are T3 Defense warrants and Series B Preferred affected by this 8-K disclosure?
On which exchange are T3 Defense (DFNS) securities listed and what is the warrant exercise price?
AI-generated analysis. How Rhea-AI works. Not financial advice.